Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone plus low-dose isotretinoin vs standard-dose isotretinoin for adult female acne
ChiCTR2100042752Phase 4Recruiting
- Sponsor
- The University of Hong Kong-Shenzhen Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in acne vulgaris comparing Spironolactone + low-dose isotretinoin with Standard-dose isotretinoin (2 arms). Primary endpoint: Severity of acne. Started Jan 2021; status: recruiting.
02
Drugs
isotretinoinspironolactone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on ChiCTR2100042752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042752.